Title
Category
Credits
Event date
Cost
  • Disease management
  • Rare diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This presentation exams the challenges surrounding rare-disease diagnosis and treatment, delving further into the significant impact of the diagnostic odyssey on adults, children, and their families as they seek care for their rare conditions. A panel of individuals speak about the challenges of their own rare-disease odysseys and provide insight into the pronounced effects their prolonged and necessary diagnostic pursuits have had on their personal lives, finances, and physical and mental health.
  • Behavioral health
  • Disease management
  • Wellness
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will outline racial and socioeconomic status disparities and provide examples of why they may exist among different populations, identify challenges associated with the diagnosis and management of obesity, including diagnostic accuracy, access to care, and impact on health care costs and quality of life and discuss potential interventions that can reduce obesity care inequities.
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will review the interrelationship of pain and sleep on physical activity, stress and behavior, as well as the importance of assessing sleep quality for individuals with pain. Dr. Schubiner will also highlight techniques to reduce stress and improve sleep.
  • Disease management
  • Older adults
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 ASWB - Social Workers
$0.00
This activity will discuss challenges surrounding hearing health care for individuals with hearing loss, including older adults, and highlight effective techniques, tools and resources for these individuals.
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This patient‑led interview offers a compelling perspective on the real‑world impact of gene therapy for sickle cell disease, highlighting both dramatic physical improvements and the psychological and social adjustments that can follow transformative treatment. Through the patient’s lived experience, learners gain insight into how gene therapy may redefine identity, daily functioning, and long‑term expectations for health. The interview emphasizes the importance of patient‑centered communication, listening to patient expertise, and supporting ongoing mental and emotional adaptation as part of comprehensive, team‑based care.
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview explores the rapidly evolving role of gene therapy through a practical, clinician‑focused lens. Rather than emphasizing future speculation, the discussion centers on what health care professionals need to know now—how gene-based therapies are entering clinical practice, current understanding of safety and efficacy and the role of clinicians across care settings. By addressing common knowledge gaps between specialists and primary care clinicians and using relatable comparisons to established therapies, the interview highlights the importance of patient education, interdisciplinary communication and timely referral as gene‑based treatments continue to expand.
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview equips clinicians with practical strategies to identify and manage metabolic‑associated fatty liver disease in everyday practice. Emphasizing early detection in an often asymptomatic population, the discussion focuses on using cardiometabolic risk factors and simple, noninvasive tools such as fibrosis 4 (FIB‑4) to stratify risk and guide next steps. By reinforcing a stepwise, team‑based approach to evaluation, referral and evidence‑based management, the interview helps learners translate emerging advances into timely, actionable care for patients at risk.
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Gene therapy technologies are revolutionizing treatment for genetic diseases. This session explores the science, clinical applications, and patient perspectives, with a focus on sickle cell disease and emerging technologies like CRISPR.
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
This session explores the latest updates in the diagnosis and management of chronic obstructive pulmonary disease (COPD) as outlined in the 2025 GOLD Report. Early case finding, refined spirometry protocols and novel therapeutic options are discussed, along with the importance of pre-bronchodilator spirometry, strategies for early detection in at-risk populations, and the integration of new treatments into updated treatment algorithms.
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Heart failure remains a leading cause of hospitalization and mortality. This session focuses on recognizing early signs, diagnostic tools, and evidence-based strategies to optimize care, improve patient quality of life, and reduce readmissions.

Pages